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A partial　 amino　 acid　 sequence　 of　the　 α-polypeptide　 chain　 in　hemoglobin
from macaca mulatta monkey was determined and compared with the known 
sequence of the corresponding part of human hemoglobin. Two differences 
were discovered between them.
　　　 The　 α-polypeptide　 chain　 of　macaca　 mulatta　 monkey　 hemoglobin　 was　 hy-
drolyzed　 with　 trypsin.　 Three　 tryptic　 peptides,　 α.T9,　 αT10,　 and　 αT11　 were
the　 subjects　 of　this　 experiment.　 αT9　 was　 further　 hydrolyzed　 with　 pepsin
and　 then　 the　 amino　 acld　 sequence　 of αT9　 was　 determined　 by　 arranging
partial sequences of those peptic peptides which were determined by PTC
and　 DNP　 methods.　 The　 sequences　 of　αT10　 and　 αT11　 were　 directly　 deter-
mined by PTC and DNP methods. The comparison of the results thus obta-
ined with the known sequence of human hemoglobin showed that there were
two　 differences　 only　 in　 αT9.　 Namely,　 the　 seventh　 and　 the　 tenth　 amino
acid residues from the N-terminus were respectively asparagine and alanine 
in human hemoglobin, but leucine and glycine in macaca mulatta monkey 
hemoglobin.
                  INTRODUCTION 
   Problems on the evolution of living things have in general been 
discussed from the viewpoint of comparative studies of their physical 
shapes and their habits. Considering that they are all of chemical 
constituents, however, the comparative studies of their chemical com-
ponents on molecular level can also be very suggestive to this kind of 
problems. By the comparison of the structures of proteins from various 
kinds of living things, ANFINSEN" presumed the evolutional process of 
gene which is considered to be the regulator of protein biosyuthesis. 
This is quite a new and different way from DARWIN and his disciples'. 
This new theory appears reasonable judging from the recent discovery 
that amino acid sequences of proteins are under the control of base
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sequence of gene, DNA. Now that it is impossibe to elucidate the 
detail of the gene structure by itself, the determination of the amino 
acid sequences of proteins from various kinds of animals is suggestive 
to deduce the gene structure. 
   Hemoglobin is a good material for this purpose not merely because 
it widely distributes among the animal kingdom but because its isola-
tion and purification are relatively easier than those of other proteins. 
It is known that every hemoglobin from various animals has its own 
peculiarities on electrophoresis, in alkali-6enaturati.on and so forth, 
and that these peculiarities are not due to the protoheme of hemoglobin 
but due to slight differences in structure of the globin part from other 
hemoglobins. Such differences are presumed to be the accumulation of 
point mutations caused by the base changes of gene, DNA. 
   Conerning the primary structure of the globin part, many groups 
of workers have been studying on various kinds of animals since BRA-
UNITZER et al. 2' and KONIGSBERG et al."' determined that of human 
hemoglobin. Hemoglobins of primates have been studied by comparing 
with human hemoglobin. ZUCKERKANDLE et al. presumed that the a-
chain of chimpanzee hemoglobin was exactly the same as that of human 
hemoglobin."' They also reported that gorilla hemoglobin differed from 
human hemoglobin at one point in a-chain and one in 8-chain .211 BU-
ETTNER-JANUSCH et al." analyzed the partial amino acid compositions 
of tryptic peptides in hemoglobins from hylobates, papio, perodicticus 
galogo, and lemur, and compared them with that of human hemoglobin, 
respectively. They reported between human and lemur fulous which is 
considered to be the evolutionally remotest from human among the 
primates, there were six amino acid substitutions in ca-chain and twenty-
three in 19-chain of their hemoglobins. The comparative studies of macaca 
mulatta monkey hemoglobin with human hemoglobin show that there 
are great similarities between them immunologically20' , chromatogra-
phically193, electrophoretically$', and in alkali- denaturation5' . However, 
the slight difference on the fingerprint was proposed by ZUCKERKANCLE 
et al.26' 
   The primary structure of macaca mulatta monkey hemoglobin has 
been investigated in this laboratory. 9),13),15),16),17),21),24) According to 
the results so far obtained, there are at least eleven differences in 
the amino acid sequence between human and macacaa mulatta monkey 
hemoglobins. The present author reports here on a partial amino acid 
sequence of the a-polypeptide chain in macaca mulatta monkey hemoglo-
bin. 
             MATERIALS AND METHODS 
1) Preparation of the a-Polypeptide Chain 
    Hemoglobin was prepared from blood of a macaca mulatta monkey
by D2AIBKIN's method.(,' It was dehemed in acetone containing HCI 
according to the method of ANSON and MERSKY. "Separation into a- and 
i9-polypeptide chains was performed by countercurrent distribution 
method with the system of sec-butanol containing 0.08% trichloroaceti-c 
acid, propionic acid, and water (8.7: 1.5: 11.0) . 11) 
2) Preparation of a.T9, aTlO, and (JT11 from the a-Polypeptide Chain 
   In 8M urea, lg of the a-polypeptide chain was denatured at 60°C for 
45 minutes. After removing urea by dialysis, it was digested with 
10mg of trypsin (Worthington Biochemical Corporation, twice-crystall-
ized) at pH 8.0 for four hours at 37°C. The digest was adjusted to 
pH 6.4 with 1N acetic acid and the insoluble `core' peptides were pre-
cipitated. The soluble peptides in the supernatant were isolated and 
purified both by column chromatography with Dowex 1 x 2 as a adsor-
bent and the acetate buffer containing organic bases such as pyridine, 
collidine, lutidine, and picoline as a developer, and by paper chroma-
tography with a mixture of n-butanol and acetic acid as a developer."' 
A portion of each tryptic peptide thus obtained was subjected to the 
amino acid analysis. 
3) Digestion of the aT9 with Pepsin 
   In 30ml of deionized water, 15 pmoles of (,T9 was dissolved and 
denatured at 95°C for five minutes. After cooling, the pH was brought 
to 2.0 with 0.2N HC1. By the addition of 4mg of pepsin (Sigma Chemi-
cal Company, three-time crystallized) which was dissolved in 2ml of 
1/16N HCI, this solution was incubated at 37°C for two and a half 
hours. Then it was adjusted to pH 9.0 with 2.5N NaOH and lyophili-
zed. 
4) Isolation of Peptic Peptides from aT9 by Column Chromatography 
   The resin, Dowex 1x2 (200-400 mesh, Cl-type, Dow Chemical 
Company) was settled to remove the very fine particles and washed 
with 1N NH4OH, water, acetic acid, and water, successively. It 
was suspended with starting buffer pH 8.5 (1% pyridine, 1% 2.4 luti-
dine, and 1% (J-picoline) and thoroughly evacuated by a vacuum pump. 
The resin thus prepared was loaded in a column (0.9x60 cm), kept 
at 37°C, and equilibrated with the above-mentioned buffer overnight. 
   The sample was dissolved in 20ml of deionized water and the pH 
brought to 9.0 with 0.1N NaOH. Then it was put on the column. 
The development was performed at 37°C by using a flow rate of 100 
ml per hour. Fraction No. 1 to No.15 were eluted with the . starting 
buffer pH 8.5. The pH-gradient with acetic acid was employed from 
Fraction No.16 . Namely, Fraction No.16 to No. 75 were eluted by 
supplying 0.08 N acetic acid in the reservoir to 600m1 of the starting 
buffer in the mixing chamber. The elution of Fraction No, 76 to the 
last, the content in the resorvoir was changed into 1.ON acetic acid. 
All the organic bases used for the developer were purified by distilla-
tion and the deionized water was removed CO, by boiling an-1 thorou-
ghly evacuated. The effluent was collected in 8 ml-fractions. The pep-
tides in the effluent was detected by the ninhydrin method according 
to YEMM and CGCKING25I after an aliquot of each fraction was alkali-
hydrolyzed. To. 0.4 ml of each fraction was added 1ml of 2.5N NaOH. 
This mixture was hydrolyzed at 95°C for two and a half hours, and to 
this was added 1 ml of 30% acetic acid, 0.5 ml of 0.2M citrate buffer 
pH 5.0, and 1.2 ml of ninhydrin KCN solution. It was heated at 100°C 
for 15 minutes and then, after cooling, diluted with 3ml of 60% ethanol. 
The optical density at 570mf-z of each fraction was measured. The eff-
luent at the peaks on the chromatogram was collected respectively, 
dried under reduced pressure, dissolved again in 3 ml of deionized 
water, and finally lyophilized. 
   5) Identification and Purification of Peptides by Paper Chroma-
tography 
   The descending paper chromatography was performed on a sheet 
of Toyo filter paper No. 50 (40 x 40cm) with the upper phase of a 
mixture of n-butanol, acetic acid, and water (4:1:5). In order to detect 
peptides the paper was sprayed 0.2% ninhydrin n-butanol solution and 
heated to color with an iron. PAuLI's reaction 23' was also employed 
for identification of the peptides containing histidine. The Rf Leu value 
which expresses the relative mobility of a peptide to standard leucine 
was calculated to show the positions of peptides on the chromatogram. 
   In case of purification of these peptides, the locations of peptides 
were first confirmed by guide strips and then the appropriate areas 
were cut out. Peptides were eluted with 5% acetic acid. 
   6) Paper Electrophoresis of Peptides 
   The sample was applied on the center of a sheet of Toyo filter 
paper No. .51 (l0 x 60cm) . The electrophoresis was carried out in an 
electrophoretic apparatus (Ishidai type) at 2000 V for two hours by 
using 10% pyridine acetate buffer pH 6.4. Detection and purification 
of the peptides were performed by the same methods as in the paper 
chromatography. 
   7) DNP Method for N-Terminal Amino Acid Analyses of Peptides 
   A peptide (0.2. 0.5imole) was dissolved in 3ml of 1% NaHCO3 and 
to this was added 0.05 ml of dinitrofluorobenzene (DNFB). This rea-
ction mixture was incubated at 40°C for two hours. The excess DNFB 
was extracted with ether and then the aqueous phase acidified with 
HC1 was again extracted with ether. Consequently, dinitrophenol (DNP) 
which was considered to be a byproduct in the dinitrophenylation was 
taken off in the ether phase. The DNP-peptide remaining in the aque-
ous phase was dried, dissolved in constant boiling point HC1, and then 
hydrolyzed in a sealed tube at 105°C for 20 hours. DNP-amino acids 
were extracted with 10ml of ether three times from the hydrolysate.
This ether phase was dried under reduced pressure in a heart-shaped 
flask, the modification of MILLS' apparatus1° . Subsequently, this flask 
was connected to the cold finger and evacuated by a vacuum pump. 
Identification of the DNP-amino acids were carried out by two-dimen-
sional paper chromatography. Namely, the sample dissolved in a small 
portion of acetone was applied on a sheet of Toyo filter paper No. 51 
(40 x 40cm) . Development was performed by ascending method; the 
first dimension with the upper phase of a mixture of n-butanol and 1N 
NH4OH (1:1); the second, with 0.5M phosphate buffer. 
   8) PTC Method for Amino Acid Sequence Analyses of Peptides 
   The phenylisothiocyanation of peptides was performed in 66% pyri-
dine according to the modification of EDMAN' S original method ." Form-
ation of PTH-amino acids were carried out with trifluoroacetic acid. 
The PTH-amino acids were not identified, however, the amino acid 
compositions of the remaining peptides were analyzed. 
   A peptide (0.5-3.0amole) was dissolved in 2.5ml of 66% pyridine 
and poured in a heart-shaped flask. To this was added phenylisothiocy-
anate (PTC) and the reaction mixture allowed to stand at 37°C for 
three hours. It was dried under reduced pressure. The flask was 
connected to the cold-finger and incubated by a vacuum pump to re-
move the excess PTC. To this was added 1ml of trifluoroacetic acid. 
This was allowed to stand at room temperature for three and a half 
hours. Trifluoroacetic acid was removed under reduced pressure and 
the residue was dissolved in 3ml of deionized water. From this solu-
tion, PTH-amino acids were extracted three times with 3m1 of benzene. 
A portion of the peptide in aqueous phase was hydrolyzed with HCl, 
and the amino acid composition was analyzed. The remainder was dried 
under reduced pressure and used in the next step of the PTC method. 
Long peptides had to be further purified by paper electrophoresis. 
   9) Amino Acid Analyses of Peptides 
   A peptide was dissolved in 4ml of constant boiling point HC1 and 
hydrolyzed at 105°C for 22-24 hours in a sealed tube. The hydrhlysate 
was dried and removoed HCl thoroughly. Its amino acid composition was 
examined on an amino acid analyzer, Hitachi KLA 2 with a 7.5cm co-
lumn and a 50cm column. The analysis values were shown in molar 
ratios without correction for losses during the procedure. 
              RESULTS AND DISCUSSION
   Table I shows the amino acid compositions of the tryptic peptides, 
(1T9, (:T10, (./T11, and their yields obtained from the Cryptic hydrolysate 
of lg of the (j-polypeptide chain of macaca mulatta monkey hemoglobin. It 
was previously reported that (1T9 had four residues of aspartic acid 
and one residue of glutamic acid, 131 however, in this experiment the 
analysis values of aspartic acid and glutamic acid in (1T9 were 4.71
           Table I 
Amino acid compositions of (/T9, (IT 
10, and aT11, and their yields from 
1000 mg of the (A-polypeptide chain.
         a T9 a T10 a T11 
Lys 1.18 0.97 
His 2.87 
Arg 0.95 









.95 Met I 0.53 




Yield 18i moles 32umo_es 19umoles
and 0.21, respectively. In the 
process of sequence determina-
tion, no glutamic acid residue 
was recognized in (1T9. 
1) Amino Acid Sequence of ,:T9 
   The N-terminal residue was 
known to be v aline by DNP 
method. Fragmentary peptides 
were obtained from the peptic 
hydrolysate of (1T9. They were 
fractionated into eight peaks as 
shown in Fig. I by column ch-
romatography. Each peptide in 
a peak was purified by paper 
chromatography. Ten main pe-
ptides were obtained as shown 
in Fig. 2. Table II gives the 
amino acid compositions of these 
peptides. The sequence deter-
mination was carried out through 
the following procedure. The 
yields through the procedure
Fig. 1 Column chromatography of the peptic peptides from aT9
Fig.2 Paper chromatography of the peptic peptides from aT9.
Table II Amino acid compositions of the peptic peptides from a T9
         P-Ia P-Ha P-IIIa P-IVa P-Va P-Vb P-VIa P-VIIb P-VIIIa P-VIIIb 
 Lys 1.07 1 1.08 
 His 1.89 1.91 1.11 1.02 
MetO2 + + 
 Asp I 1.01 2.59 2.59 0.96 1.00 1.03 1.03 
 Thr 0.97 0.97 
 Ser 0.82 0.92 ! 0.71 0.70 0.90 0.94 
 Glu j 0.19 0.21 
 Pro 1.14 1.08 
 Gly 1.20 1.10 
 Ala 1.03 1.19 1.00 2.71 2.69 2.09 2.27 
 Val 1.01 2.01 2.17 0.94 0.86 
 Leu 2.03 1.08 1.15 2.19 1.03 1.07 2.02
from peptic digestion to amino acid analysis are given in percentage. 
(a) aT9 P-Ia Rf Leu 0.04 29% 
   Two steps of PTC method were performed.
        Lys His Ala 
  Step 1 1.08 1.19 0.92 
  Step 2 1.00 1.13 0.21 
    Since lysine is supposed to be the C-terminal residue of aT9, this 
peptide has a sequence of His-Ala-His-Lys and is located at the C-
terminus of (./T9. 
(b) aT9 P-11a Rf Leu 0.10 12% 
   It is supposed from the composition in Table iI that this peptide 
is a combination of P-la and P-VIIla. 
(c) uT9 P-111a Rf Leu 1.18 10% 
  Two steps of PTC method gave the following results. 
        Thr Leu 
  Step 1 1.00 1.27 
  Step 2 0.18 1.00 
  Accordingly, the sequence was determined to be Leu-Thr-Leu. 
(d) (T9 P-IVa Rf Leu 1.04 10% 
  Two steps of PTC method were carried out. 
        Ser Ala Leu 
  Step 1 0.09 0.99 1.01 
 Step 2 0.00 0.19 1.00 
  The sequence was, therefore, Ser-Ala-Leu. 
(e) a,/T9 P-Va Rf Leu 0.15 23% 
    (T9 P-Vb Rf Leu 0.25 27% 
   These two peptides consist of 13 and 14 amino acid residues, re-
spectively as shown in Table II and resemble each other except that 
P-Va has leucine one residue less than P-Vb. The remaining peptide 
of P-Vb after the first step of PTC method had the same composition 
as that of P-Va. In the previous experiment, (JT9 was digested with 
pepsin for three hours and a peptide resembling this P-Va was obta-
ined. The amino acid composition was His: 0.93, Met: (+), Asp: 
2.72,Ser: 0.95, Pro: 1.20, Gly: 1.19, Ala : 2.12, Val: 1.98, and Leu: 
1.08. The sequence analysis was tried by digesting this peptide with 
pronase P for 16 hours but failed only obtaining some dipeptides and 
amino acids. This peptide was also digested with papain for 10 hours 
to obtain two kinds of peptides whose compositions were a) Gly: 0.86, 
Ala: 1.13, Val: 1.01, and b) His: (+), Met: (+), Asp: 2.41, Pro: 
1.18, Ala : 1.16, Val : 1.21. 
   In this experiment, the amino acid sequence of this part was de-
termined by the employment of PTC method on P-Va and P-Vb. Table 
III gives the results obtained by PTC method together with the amino 
acid composition of P-Vb. The peptide after the 5th and 8th step of 
PTC method had to be purified by paper electrophoresis. The electric 
charge of the peptide on each step was examined by electrophoresis to 
distinguish between aspartic acid and asparagine. As the result, the 
eleventh residue from the N-terminus of this peptide was known to be
Table III Results of PTC method on (1T9 P-Vb
         His Met02 Asp Ser Glu Pro Gly Ala Val I Leu 
 P-Vb 1.02 (+) ~ 2.59 0.70 0.21 1 1. 08 1.10 2.69 2.17 2.19 
Step 1 0.98 (+) 2.33 1.03 trace I; 1.02 1.22 2.78 1.98 1.21 
Step 2 1.02 (+) 2.49 0.78 0.00 0.85 1.18 2.11 1.79 1.06 
Step 3 0.93 (+) 2.62 1 0.84 0.00 0.89 1.11 1.97 1.06 1.13 
Step 4 0.97 (+) 2.96 0.85 0.00 0.93 0.58 2.07 1.05 1.16 
Step 5 0.51 (+) 2.83 0.87 0.00 0.98 0.08 2.02 1.01 0.99 
Step 6 0.00 (+) 2.98 0.86 0.00 1.14 0.09 2.04 0.13 1.07 
Step 7 measured (4) 2.23 0.98 0.00 1.00 0.00 2.02 0.00 1.00 
i Step 8 /i (+) 1.63 1.04 0.00 1.03 0.00 1.91 0.21 1.02 
Step 9 ii (-) 1.12 0.88 0.00 0.95 0.00 2.13 0.00 0.92 
Step 10 Ii (-) 1.22 0.91 0.00 0.00 0.00 1.90 0.00 1.13 
Step 11 /1 (-) 0.43 1.00 0.00 0.00 0.00 1.81 0.00 1.19 
Step 12 U (-) 0.21 0.89 0.00 0.00 0.00 1.21 0.00 1.00 
Step 13 U (-) 0.25 0.91 0.00 I 0.00 0.00 1.09 0.00 0.53
asparagine. Therefore, the sequence was as follows; Leu-Ala-Val-Gly-
His-Val-Asp-Asp-Met -Pro-Asp (NH, )-Ala-Leu-(Ser, Ala). As for the 
order of serine and alanine at the C-terminus, the sequence, Ser-Ala, 
was probable from the result on ,:T9 P-IVa. 
(f) a:T9 P-VIa Rf Leu 0.72 25% 
 Three steps of PTC method were performed. 
       Asp Ala Val 
 Step 1 1.08 1.92 0.12 
 Step 2 0.93 1.22 0.00 
 Step 3 0.41 1.00 0.00 
   The elution behavior on the column chromatogram and the electro-
phoretic behavior on the paper electrophoregram showed that this pe-
ptide was acidic. The sequence was therefore determined to be Val-
Ala-Asp-Ala. 
   As described previously the N-terminal residue of (iT9 had known 
to be valine and only this peptide contained it. Therefore, it was 
considered that this peptide was located at the N-terminus of aT9. 
(g) aT9 P-VIIb Rf Leu 1.00 19% 
   The sequence of this peptide was deduced to be Val-Ala-Asp-Ala-
Leu-Thr judging from the composition in Table III and the sequences 
of P-VIIIb and P-IIIa. 
(h) aT9 P-VIIIa Rf Leu 0.60 5% 
   Two steps of PTC method were carried out. 
        Asp Ser Leu 
 Step 1 0.96 0.22 1.04 
 Step 2 0.24 0.00 1.00 
   Since this peptide was known to be acidic, the sequence was Ser-
Asp-Leu. 
(i) aT9 P-VIIIb Rf Leu 0.98 21% 
   Three steps of PTC method were carried out. 
        Asp Ser Leu 
 Step 1 0.98 0.92 1.10 
 Step 2 0.95 0.10 1.05 
 Step 3 0.20 0.00 1.00 
   This result indicates that this peptide was the combination of a 
leucine residue and P-VIIIa at its N-terminus. The sequence was Leu-
Ser-Asp-Leu. 
   The amino acid sequences of the ten peptides obtained by peptic 
digestion of aT9 were determined as described above. The peptide 
sequence in aT9 was determined as shown Fig. 3, considering that 
P-VIa and P-VIIb had known to be located in the N-terminus of aT9 
and P-1a and P-11a, in the C-terminus. 
   The comparion of the amino acid sequence of this aT9 with that 
of human hemoglobin showed two differences between them. Namely, 
the seventh residue from the N-terminus of (T9 is asparagine in human 
hemoglobin, but leucine in macaca mulatta monkey hemoglobin. Similarly 
the tenth from the N-terminus is alanine in the former but glycine in 
the latter. It was elucidated that (:T9 of macata mulatta monkey hemo-
globin had no glutamic acid residues.
Fig. 3 The amino acid sequence of aT9
2) Amino Acid Sequence of (T10 
   As shown in Table I, this is a dipeptide containing leucine and 
arginine. Since it was a tryptic peptide, the sequence was deduced to 
be Leu-Arg. 
   It was confirmed by DNP method for the N-terminal analysis.
3) Amin Acid Sequence of vT11 
   This peptide containing seven amino acids as shown in Table I was 
subjected to five steps of PTC method for the sequence determination. 
        Asp Pro Val Phe Lys 
  Step 1 2.06 1.00 0.97 0.98 not determined 
 Step 2 1.18 0.94 0.95 0.92 
 Step 3 1.12 0.19 0.92 0.95 
 Step 4 1.09 0.00 0.28 0.91 
 Step 5 0.48 0.00 0.14 1.00 ~. 
   This peptide was originally neutral, however, it was known by 
paper electrophoresis that after the second step of PTC method the 
remaining peptide after each step changed into basic. This indicates 
that aspartic acid was eliminated in the second step and, asparagine, 
in the fifth step. Since lysine was supposed to be the C-terminal resi-
due, the sequence of (iT11 was determined to be Val-Asp-Pro-Val-Asp 
(NH2 )-Phe-Lys. This is quite similar to the corresponding peptide in 
human hemoglobin. 
                   CONCLUSION 
   The sequence of thirty-eight amino acid residues contained in the 
tryptic peptides, (:T9, aT10, uT11 of the (A-polypeptide chain in macaca 
m.ulatta monkey hemoglobin was determined. The comparison of the 
corresponding sequences between human and macaca mulata monkey 
hemoglobins demonstrated two amino acid substitutions in (:T9. They 
were Asp (NH2 ) Chuman) ---* Leu Cmonkey) and Ala Chuman) -* 
Gly (monkey]. The sequences of other 36 residues were all the same 
as each other. 
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